November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 22, 2026
According to our forecasts, the genitourinary drugs market was valued at approximately USD 30.1 billion in 2025 and is projected to grow from USD 30.45 billion in 2026 to nearly USD 33.75 billion by 2035, registering a CAGR of 1.15% during the forecast period....
January 21, 2026
Projections indicate that, the global anti-obesity drugs market will increase from USD 9.11 billion in 2025 to USD 99.74 billion by 2035, experiencing a CAGR of 27.04% over the next 10 years. In 2024, North America led the anti-obesity drugs market, with Asia Pacific set for the fastest growth. Prescription drugs dominated, while OTC drugs are pois...
January 21, 2026
Based on our market forecasts, the hemophilia inhibitors sector will expand from USD 16.43 billion in 2025 to USD 29.54 billion by 2035, experiencing a CAGR of 6.04%....
January 21, 2026
According to market projections, the polycystic ovary syndrome treatment sector is expected to grow from USD 5.15 billion in 2025 to USD 9.72 billion by 2035, reflecting a CAGR of 6.56%. The primary need for PCOS treatment is due to the rising concerns related to infertility, metabolic issues, pregnancy complications, mental health disorders, etc. ...
January 21, 2026
Based on market forecasts, the Europe behavioral health market, projected at USD 36.82 billion in 2025, is expected to reach USD 67.12 billion by 2035, growing at a CAGR of 6.19% over the forecast period. The Europe behavioral health market is expanding due to growing mental health awareness....
January 21, 2026
Our projections indicate that, the non-viral gene delivery technologies market covers comprehensive statistical insights including market size valued at USD 4.69 billion in 2026 and projected to reach USD 13.38 billion by 2035, expanding at a CAGR of 12.34% during the forecast period....
January 20, 2026
Based on market forecasts, the personalized medicine sector will expand from USD 620.14 billion in 2025 to USD 1368.89 billion by 2035, experiencing a CAGR of 8.24%. The ever-increasing personalized medicine market, due to personalized medicine, aims to make more accurate diagnoses, improve treatment outcomes, and reduce side effects by tailoring t...
January 20, 2026
The GLP-1 receptor agonist market size is calculated at $62.86 bn in 2025 is to hit $315.33 bn by 2035. GLP-1 receptor agonists are peptide drugs that mimic the GLP-1 hormone to lower blood glucose and aid weight loss. With rising diabetes and obesity rates, the market is growing. Recent developments include Eli Lilly's Zepbound, Novo Nordisk's par...
January 20, 2026
Projections indicate the global chemotherapy market will increase from USD 10.29 billion in 2025 to USD 21.33 billion by 2035, experiencing a CAGR of 7.56% over the next 10 years. In 2024, North America led the global chemotherapy market with a 45% share. The Asia Pacific region is expected to grow the fastest. Alkylating agents dominated, while le...
January 20, 2026
According to our projections, the U.S. cell and gene therapy clinical trials market was valued at USD 5.41 billion in 2025 and is projected to grow from USD 6.26 billion in 2026 to USD 23.14 billion by 2035, registering a CAGR of 15.64% during 2026 to 2035....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com